BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the ...
FORT WORTH, Texas, March 2, 2020 /PRNewswire/ -- Eyevance Pharmaceuticals, committed to developing and commercializing innovative and impactful ophthalmic products ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Applications (NDAs) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback